Clinical Outcomes and Urodynamic Effects of Tailored Transvaginal Mesh Surgery for Pelvic Organ Prolapse

Table 4

Linear regression analysis of the change from baseline with this novel surgery compared to our prior study [7].

Variables	Baseline		Change from baseline at 3 months
	This study; ( = 58)	Prior study [7]; ( = 21)	This study; ( = 58)	Prior study [7]; ( = 21)
Pad weight (g)	29.3 ± 43.1	5.9 ± 14.6	−22.9 ± 38.5	3.7 ± 16.3	0.005
max (mL/s)	20.5 ± 10.4	22.3 ± 12.0	3.9 ± 22.2	−0.6 ± 11.0	0.38
VV (mL)	302 ± 146	350 ± 129	−5 ± 164	−19 ± 123	0.73
PVR (mL)	51.4 ± 29.4	100.7 ± 59.9	−16.3 ± 29.4	−13.4 ± 80.9	0.82
SD (mL)	250 ± 58.0	307 ± 78	12 ± 51	−1.8 ± 90.4	0.39
Pdetmax (cmH2O)	22.2 ± 12.9	27.6 ± 17.6	8.4 ± 30.2	−1.7 ± 16.9	0.17
MUP (cmH2O)	104.7 ± 29.7	103.0 ± 27.3	−19.1 ± 27.1	−20.7 ± 28.7	0.63
MUCP (cmH2O)	62.4 ± 26.6	70.4 ± 24.7	−21.1 ± 27.3	−21.3 ± 24.5	0.97
FPL (cm)	2.6 ± 0.7	3.4 ± 0.8	−0.2 ± 0.9	0.2 ± 1.3	0.12
PTR at MUP (%)	108 ± 51	101 ± 48	−9 ± 54	−14 ± 48	0.68
DO	7	6	2	8	0.58

The values are expressed as the mean ± standard deviation or patient number.
Wilcoxon rank-sum test.
McNemar's test.
Abbreviations are the same as in Table 2.